Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide

Australian and New Zealand Journal of Ophthalmology

Volumn 26, Issue 3, 1998, Pages 231-236

  Murdoch, D ^a   Gray, T B ^a   Cursons, R ^a   Parr, D ^a  

^a NONE   (New Zealand)

Author keywords

Acanthamoeba keratitis; Bacterial endosymbionts; Polyhexamethylene biguanide resistance

Indexed keywords

HEXAMIDINE; POLY(HEXAMETHYLENEBIGUANIDE); PROPAMIDINE;

ACANTHAMOEBA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTACT LENS; FEMALE; HUMAN; INCIDENCE; INFECTION RISK; KERATITIS; MALE; NEW ZEALAND; PARASITE IDENTIFICATION;

EID: 0031853361     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1998.tb01317.x     Document Type: Article

References (23)

1. 1 Jackson TN, Heinze JB, Tuxen J, Weiner JM. Successful medical treatment of a corneal ulcer due to Acanthamoeba polyphaga. Aust. N. Z. J. Ophthalmol. 1986 ; 14: 139–42.
2. 2 Tay‐Kearney M‐L, McGhee CNJ, Crawford GC, Trown K. Acanthamoeba keratitis: A masquerade of presentation in six cases. Aust. N. Z. J. Ophthalmol. 1993 ; 21: 237–45.
3. 3 Gray TB, Gross KA, Cursons RTM, Shewan JF. Acanthamoeba keratitis: A sobering case and a promising new treatment. Aust. N. Z. J. Ophthalmol. 1994 ; 22: 73–6.
4. 4 D'Amico DJ, Caspers‐Velu L, Libert J et al. Comparative toxicity of intravitreal aminoglycoside antibiotics. Am. J. Ophthalmol. 1985 ; 100: 264–75.
5. 5 Jones DB, Visvesvara GS, Robinson NM. Acanthamoeba polyphaga keratitis and acanthamoeba uveitis associated with fatal meningoencephalitis. Trans. Ophthalmol. Soc. UK 1975 ; 95: 221–32.
6. 6 Bacon AS, Frazer DG, Dart JKG, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of acanthamoeba keratitis, 1984–1992. Eye 1993 ; 7: 719–25.
7. 7 Radford CF, Bacon AS, Dart JKG, Minassian DC. Risk factors for acanthamoeba keratitis in contact lens users: A casecontrol study. BMJ 1995 ; 310: 1567–70.
8. 8 Levey SB, Cohen EJ. Methods of disinfecting contact lenses to avoid corneal disorders. Surv. Ophthalmol. 1996 ; 41: 245–51.
9. 9 Gautom RK, Fritsche TR. Characterisation of bacterial endosymbionts of Acanthamoeba spp. In: 7th International Conference on Small Freeliving Amoebae. 1996, Adelaide, SA, Australia. (Abstract).
10. 10 Macsai MS, Hall JE. The effect of bacterial endosymbionts on the temperature dependent growth and cytopathogenicity of Acanthamoeba. Invest. Opthalmol. Vis. Sci. 1996 ; Suppl.: S420.
11. 11 Wright P, Warhurst D, Jones BR. Acanthamoeba keratitis successfully treated medically. Br. J. Ophthalmol. 1985 ; 69: 778–82.
12. 12 Seal D, Hay J, Kirkness C et al. Successful medical therapy of acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996 ; 10: 413–21.
13. 13 Johns KJ, Head WS, O'Day DM. Corneal toxicity of propamidine. Arch. Ophthalmol. 1988, 106: 68–9.
14. 14 Colin J, Nalet F, Richard C. Successful treatment of superficial acanthamoeba keratitis with 0.1% hexamidine ophthalmic solution. Ophthalmology 1995 ; 102–9A: 129.
15. 15 Brasseur G, Favenec L, Perrine D, Chenu JP, Brasseur P. Successful treatment of acanthamoeba keratitis by hexamidine. Cornea 1994 ; 13: 459–62.
16. 16 Olle‐dela Haye P, Zafirakis E, Akpek E, Brasseur G, Eupherte L, Foster CS. Acanthamoeba keratitis: Efficiency of hexamidine vs propamidine in vivo and in vitro. Invest. Ophthalmol. Vis. Sci. 1997 ; Suppl.: S230.
17. 17 Larkin DFP, Kilvington S, Dart JKG. Treatment of acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992 ; 99: 185–91.
18. 18 Dawson MW, Brown TJ, Till DG. The effect of Baquacil on free‐living amoebae. N. Z. J. Mar. Freshwat. Res. 1983 ; 17: 305–30.
19. 19 Elder MJ, Kilvington S, Dart JKG. A clinicopathological study of in vitro sensitivity testing and acanthamoeba keratitis. Invest. Opthalmol. Vis. Sci. 1994 ; 35: 1059–64.
20. 20 Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and acanthamoeba keratitis: The quest for alternative antiprotozoal chemotherapy. Eye 1994 ; 8: 555–63.
21. 21 Ishibashi Y, Matsumoto Y, Kabata T et al. Oral itraconazole and topical miconazole with debridement for acanthamoeba keratitis. Am. J. Ophthalmol. 1990 ; 109: 121–6.
22. 22 Holland GN, Donzis PB. Rapid resolution of early acanthamoeba keratitis after epithelial debridement. Am. J. Ophthalmol. 1987 ; 104: 87–9.
23. 23 Brooks JG, Coster DJ, Badenoch PR. Acanthamoeba keratitis: Resolution after epithelial debridement. Cornea 1994 ; 13: 186–9.